{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:59:32Z","timestamp":1792789172322,"version":"4.5.0"},"reference-count":39,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chaire Industrielle-Alliance de recherche en leuc\u00e9mie de l\u2019Universit\u00e9 de Montr\u00e9al"},{"name":"Cancer Research Network of the Fonds de Recherche du Qu\u00e9bec\u2013Sant\u00e9"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background:\u00a0KMT2A rearrangements are major genetic entities in the classification of acute myeloid leukemias (AMLs), but their diverse and frequently cryptic nature makes their detection and characterization challenging. Karyotypic anomalies at the KMT2A locus and\/or abnormal KMT2A Fluorescence in situ hybridization (FISH) results strongly indicate a KMT2A fusion, but the identification of the translocation partner gene often requires further investigation. KMT2A partial tandem duplications (PTDs), on the other hand, are undetectable by standard cytogenetics methods. Methods: We herein report the optical genome mapping (OGM) analysis of 38 AML samples: 12 cryptic\/hard-to-characterize KMT2A fusions, 20 KMT2A-PTDs and 6 cases with no KMT2A anomaly. Results: In all the fusion cases, the rearrangement between 5\u2019KMT2A and the 3\u2019partner gene was identified as a translocation t(v;11q23.3)(v;118479068), and the analysis of co-occurring variants elucidated the formation of the rearrangement. The KMT2A variants detected in the KMT2A-PTD cases were surprisingly diverse. Combined with RNAseq data, OGM analysis identified 9 distinct in-frame KMT2A-PTD variants among the 20 cases analyzed. Conclusions: With the clinical development of menin inhibitors for the treatment of patients with KMT2A-rearranged acute leukemias, the characterization of these rearrangements is of utmost importance. Our results suggest that OGM is a promising tool for accurate genetic diagnosis in this context.<\/jats:p>","DOI":"10.3390\/cancers16244171","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T10:08:53Z","timestamp":1734343733000},"page":"4171","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Unveiling the Complexity of KMT2A Rearrangements in Acute Myeloid Leukemias with Optical Genome Mapping"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8065-4011","authenticated-orcid":false,"given":"Sandrine A.","family":"Lacoste","sequence":"first","affiliation":[{"name":"Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montr\u00e9al, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Gagnon","sequence":"additional","affiliation":[{"name":"Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montr\u00e9al, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6324-2363","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"B\u00e9liveau","sequence":"additional","affiliation":[{"name":"Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montr\u00e9al, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lavall\u00e9e","sequence":"additional","affiliation":[{"name":"Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montr\u00e9al, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6319-248X","authenticated-orcid":false,"given":"Vanessa","family":"Collin","sequence":"additional","affiliation":[{"name":"Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montr\u00e9al, QC H1T 2M4, Canada"},{"name":"Cytogenetics Laboratory, Maisonneuve-Rosemont Hospital, Montr\u00e9al, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2267-1353","authenticated-orcid":false,"given":"Jos\u00e9e","family":"H\u00e9bert","sequence":"additional","affiliation":[{"name":"Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montr\u00e9al, QC H1T 2M4, Canada"},{"name":"Cytogenetics Laboratory, Maisonneuve-Rosemont Hospital, Montr\u00e9al, QC H1T 2M4, Canada"},{"name":"Division of Hematology-Oncology and Cellular Therapy, Maisonneuve-Rosemont Hospital, Montr\u00e9al, QC H1T 2M4, Canada"},{"name":"Department of Medicine, Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H3T 1J4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41375-022-01625-x","article-title":"The WHO Classification of Haematolymphoid Tumours","volume":"36","author":"Cree","year":"2022","journal-title":"Leukemia"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and Management of AML in Adults: 2022 Recommendations from an International Expert Panel on Behalf of the ELN","volume":"140","author":"Wei","year":"2022","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"EVIDoa2200008","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular International Prognostic Scoring System for Myelodysplastic Syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cancergen.2019.10.006","article-title":"Cytogenetic and Molecular Genetic Characterization of KMT2A-PTD Positive Acute Myeloid Leukemia in Comparison to KMT2A-Rearranged Acute Myeloid Leukemia","volume":"240","author":"Vetro","year":"2020","journal-title":"Cancer Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e062376","DOI":"10.1136\/bmjopen-2022-062376","article-title":"Prognostic Significance of KMT2A-PTD in Patients with Acute Myeloid Leukaemia: A Systematic Review and Meta-Analysis","volume":"13","author":"Ye","year":"2023","journal-title":"BMJ Open"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Antherieu, G., Bidet, A., Huet, S., Hayette, S., Migeon, M., Boureau, L., Sujobert, P., Thomas, X., Ghesqui\u00e8res, H., and Pigneux, A. (2021). Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication. Cancers, 13.","DOI":"10.3390\/cancers13092272"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Matthews, A.H., Pratz, K.W., and Carroll, M.P. (2022). Targeting Menin and CD47 to Address Unmet Needs in Acute Myeloid Leukemia. Cancers, 14.","DOI":"10.3390\/cancers14235906"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","article-title":"The Menin Inhibitor Revumenib in KMT2A-Rearranged or NPM1-Mutant Leukaemia","volume":"615","author":"Issa","year":"2023","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Issa, G.C., Aldoss, I., Thirman, M.J., DiPersio, J., Arellano, M., Blachly, J.S., Mannis, G.N., Perl, A., Dickens, D.S., and McMahon, C.M. (J. Clin. Oncol., 2024). Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101), J. Clin. Oncol., Epub ahead of print.","DOI":"10.1200\/JCO.24.00826"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41375-024-02261-3","article-title":"The KMT2A\/MLL Consensus Gene Structure: A Comprehensive Update for Research and Diagnostic Implications","volume":"38","author":"Meyer","year":"2024","journal-title":"Leukemia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.leukres.2014.11.017","article-title":"Evidence-Based RT-PCR Methods for the Detection of the 8 Most Common MLL Aberrations in Acute Leukemias","volume":"39","author":"Burmeister","year":"2015","journal-title":"Leuk. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1073\/pnas.0406994102","article-title":"Diagnostic Tool for the Identification of MLL Rearrangements Including Unknown Partner Genes","volume":"102","author":"Meyer","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41375-019-0451-7","article-title":"Human MLL\/KMT2A Gene Exhibits a Second Breakpoint Cluster Region for Recurrent MLL-USP2 Fusions","volume":"33","author":"Meyer","year":"2019","journal-title":"Leukemia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41467-019-09374-9","article-title":"Diagnosis of Fusion Genes Using Targeted RNA Sequencing","volume":"10","author":"Heyer","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/10408363.2020.1844135","article-title":"Cytogenetic and Molecular Genetic Methods for Chromosomal Translocations Detection with Reference to the KMT2A\/MLL Gene","volume":"58","author":"Lomov","year":"2021","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A Recombinome of Acute Leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/gcc.22741","article-title":"Acute Leukemias Harboring KMT2A\/MLLT10 Fusion: A 10-Year Experience from a Single Genomics Laboratory","volume":"58","author":"Peterson","year":"2019","journal-title":"Genes. Chromosomes Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1182\/bloodadvances.2022007613","article-title":"Allelic Complexity of KMT2A Partial Tandem Duplications in Acute Myeloid Leukemia and Myelodysplastic Syndromes","volume":"6","author":"Tsai","year":"2022","journal-title":"Blood Adv."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jmoldx.2021.07.019","article-title":"The Application of Targeted RNA Sequencing for KMT2A\u2013Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia","volume":"23","author":"Dai","year":"2021","journal-title":"J. Mol. Diagn."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.ejca.2010.02.019","article-title":"Low Frequency of MLL-Partial Tandem Duplications in Paediatric Acute Myeloid Leukaemia Using MLPA as a Novel DNA Screenings Technique","volume":"46","author":"Balgobind","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Seto, A., Downs, G., King, O., Salehi-Rad, S., Baptista, A., Chin, K., Grenier, S., Nwachukwu, B., Tierens, A., and Minden, M.D. (2024). Genomic Characterization of Partial Tandem Duplication Involving the KMT2A Gene in Adult Acute Myeloid Leukemia. Cancers, 16.","DOI":"10.20944\/preprints202403.0904.v1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/ijc.33942","article-title":"Optical Genome Mapping Reveals Additional Prognostic Information Compared to Conventional Cytogenetics in AML\/MDS Patients","volume":"150","author":"Gerding","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41375-022-01652-8","article-title":"High-Resolution Structural Variant Profiling of Myelodysplastic Syndromes by Optical Genome Mapping Uncovers Cryptic Aberrations of Prognostic and Therapeutic Significance","volume":"36","author":"Yang","year":"2022","journal-title":"Leukemia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41408-022-00718-1","article-title":"Optical Genome Mapping Refines Cytogenetic Diagnostics, Prognostic Stratification and Provides New Molecular Insights in Adult MDS\/AML Patients","volume":"12","author":"Balducci","year":"2022","journal-title":"Blood Cancer J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ajh.27175","article-title":"A Framework for the Clinical Implementation of Optical Genome Mapping in Hematologic Malignancies","volume":"99","author":"Levy","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/ajh.27435","article-title":"Optical Genome Mapping Improves the Accuracy of Classification, Risk Stratification, and Personalized Treatment Strategies for Patients with Acute Myeloid Leukemia","volume":"99","author":"Loghavi","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_27","unstructured":"(2018, November 01). Fusioncatcher\/Doc\/Manual.Md at Master \u00b7 Ndaniel\/Fusioncatcher. Available online: https:\/\/github.com\/ndaniel\/fusioncatcher\/blob\/master\/doc\/manual.md."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ng.3371","article-title":"The Transcriptomic Landscape and Directed Chemical Interrogation of MLL-Rearranged Acute Myeloid Leukemias","volume":"47","author":"Baccelli","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e201900336","DOI":"10.26508\/lsa.201900336","article-title":"Targeted Variant Detection Using Unaligned RNA-Seq Reads","volume":"2","author":"Audemard","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"ref_30","unstructured":"Bionano Genomics (2024, May 06). VIA Software Theory of Operations\u2014CG-00042, Available online: https:\/\/bionano.com\/wp-content\/uploads\/2023\/09\/CG-00042-VIA-Software-Theory-of-Operations.pdf."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng.3774","article-title":"CIViC Is a Community Knowledgebase for Expert Crowdsourcing the Clinical Interpretation of Variants in Cancer","volume":"49","author":"Griffith","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41586-022-04558-8","article-title":"A Joint NCBI and EMBL-EBI Transcript Set for Clinical Genomics and Research","volume":"604","author":"Morales","year":"2022","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000535684","article-title":"ISCN Standing Committee Genome Mapping Nomenclature","volume":"163","author":"Moore","year":"2023","journal-title":"Cytogenet. Genome Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Basu, S., Nandy, A., and Biswas, D. (2020). Keeping RNA Polymerase II on the Run: Functions of MLL Fusion Partners in Transcriptional Regulation. Biochim. Biophys. Acta Gene Regul. Mech., 1863.","DOI":"10.1016\/j.bbagrm.2020.194563"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Castiglioni, S., Di Fede, E., Bernardelli, C., Lettieri, A., Parodi, C., Grazioli, P., Colombo, E.A., Ancona, S., Milani, D., and Ottaviano, E. (2022). KMT2A: Umbrella Gene for Multiple Diseases. Genes, 13.","DOI":"10.3390\/genes13030514"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1038\/s41388-021-01983-3","article-title":"The Role of Reciprocal Fusions in MLL-r Acute Leukemia: Studying the Chromosomal Translocation t(6;11)","volume":"40","author":"Kundu","year":"2021","journal-title":"Oncogene"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1038\/s41388-021-02001-2","article-title":"The Role of Reciprocal Fusions in MLL-r Acute Leukemia: Studying the Chromosomal Translocation t(4;11)","volume":"40","author":"Wilhelm","year":"2021","journal-title":"Oncogene"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/blood-2023-172422","article-title":"A First-in-Human Phase 1 Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in Adult Patients with Relapsed\/Refractory Acute Leukemia Harboring KMT2A or NPM1 Alterations","volume":"142","author":"Jabbour","year":"2023","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/bloodadvances.2022007583","article-title":"Optical Genome Mapping in Acute Myeloid Leukemia: A Multicenter Evaluation","volume":"7","author":"Levy","year":"2023","journal-title":"Blood Adv."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/24\/4171\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:55:23Z","timestamp":1760115323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/24\/4171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,14]]},"references-count":39,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["cancers16244171"],"URL":"https:\/\/doi.org\/10.3390\/cancers16244171","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,14]]}}}